International Psoriasis Council

Advancing Knowledge. Improving Care.

45-year-old patient with a history of untreated or inadequately managed psoriasis, with no significant improvement from topical treatments (e.g., corticosteroids or vitamin D analogs). Systemic therapies or biologics had not been administered. Relevant Clinical Information: The plaques presented with thick, grayish scaling and post-inflammatory hyperpigmentation on skin type V. The condition affected high-impact areas such as the scalp, palms, and soles, leading to functional impairment and reduced quality of life.

1AE – Phenotypes

What's New

Use and Misuse of Systemic Corticosteroids in Psoriasis

In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of systemic corticosteroids in psoriasis. He questions whether they contraindicate the treatment of psoriasis, while also covering his personal experience in prescribing them.

WATCH NOW

Thursday, May 14, 2026

Use and Misuse of Topical Corticosteroids in Psoriasis

In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of topical corticosteroids in psoriasis, covering current use, guidelines, and consequences.

WATCH NOW

Thursday, May 14, 2026

Videos Now Available from the IEC & IPC Joint Symposium at AAD

Missed the joint symposium hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the American Academy of Dermatology (AAD) Annual Meeting? Select presentations from Psoriasis or Dermatitis? When Boundaries Blur and Treatments Flip the Script are now available, covering diagnostic overlap, emerging tools, treatment-related reactions, and practical strategies for managing complex cases across diverse patient populations.

WATCH NOW

Wednesday, May 27, 2026